Koers Inovio Pharmaceuticals Inc Nyse
Aandelen
US45773H1023
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
14/05 | INOVIO PHARMACEUTICALS, INC. : Stephens Inc. ontvangt een koopadvies | ZM |
13/05 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Omzet 2024 * | 418K 384K | Omzet 2025 * | 19,8 mln. 18,22 mln. | Marktkapitalisatie | 331 mln. 305 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -120 mln. -110 mln. | Nettowinst (verlies) 2025 * | -100 mln. -92,02 mln. | EV/omzet 2024 * | 793 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 16,7 x |
K/w-verhouding 2024 * |
-2,79
x | K/w-verhouding 2025 * |
-3,98
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,53% |
Recentste transcriptie over Inovio Pharmaceuticals Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25-03-19 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 01-06-02 |
Chief Tech/Sci/R&D Officer | - | 01-02-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 01-12-03 |
Lota Zoth
BRD | Director/Board Member | 64 | 01-01-18 |
Jay Shepard
BRD | Director/Board Member | 65 | 15-01-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,85 mld. | |
-0,09% | 42,82 mld. | |
+49,62% | 42,03 mld. | |
-4,96% | 29,55 mld. | |
+11,18% | 26,11 mld. | |
-21,95% | 19,13 mld. | |
+8,61% | 13,05 mld. | |
+28,31% | 12,16 mld. | |
+24,73% | 12,08 mld. |